Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | PO / MO |
The patient took first two doses of Vivotif and then missed a week; Case reference number US-BN-2025-001479 is a spontaneous case initially received from pharmacist via Communication (reference number: USBAV25-2165) on 28-Aug-2025 and concerns a female patient of an unspecified age. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient took the first dose of Vivotif (batch number: unknown) at an unknown dose, orally for indication of pre-travel. On an unspecified date, an unknown amount of time after the first dose, the patient took the second dose of Vivotif (batch number: unknown) at an unknown dose, orally. As reported a week after the second dose, the patient did not receive the third dose of Vivotif (coded explicitly as 'incomplete course of vaccination'). At the time of initial report, it was unknown if the patient experienced any adverse events due to Vivotif. No further information was provided.; Reporter's Comments: A female patient of an unspecified age did not receive the third dose of Vivotif, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of an unspecified age did not receive the third dose of Vivotif, which is considered as incomplete course of vaccination. It was unknown if the patient experienced any adverse events due to Vivotif. Incomplete course of vaccination is considered as listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.